{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/immunizations-travel/management/tetanus/","result":{"pageContext":{"chapter":{"id":"8c237a0e-a760-55b2-b7b0-5383b7653be3","slug":"tetanus","fullItemName":"Scenario: Tetanus","depth":2,"htmlHeader":"<!-- begin field 0dc17bd0-7cc5-477b-ab64-8df3839870c1 --><h2>Scenario: Tetanus</h2><!-- end field 0dc17bd0-7cc5-477b-ab64-8df3839870c1 -->","summary":"Covers advice for people travelling to areas with poor healthcare provision where post-exposure treatment might be unavailable or difficult to obtain.","htmlStringContent":"<!-- begin item 8895801f-c681-484f-8045-3dd9dc9dc89a --><!-- begin field 3d15dda5-4fb9-4cec-8f12-acd900ab5248 --><p>From age 2 months onwards.</p><!-- end field 3d15dda5-4fb9-4cec-8f12-acd900ab5248 --><!-- end item 8895801f-c681-484f-8045-3dd9dc9dc89a -->","topic":{"id":"8f89ca7f-a4f5-5e7d-80c8-de5db64ca7f0","topicId":"16d61716-d647-48bc-827b-b2b115ecd0fb","topicName":"Immunizations - travel","slug":"immunizations-travel","lastRevised":"Last revised in January 2021","chapters":[{"id":"25b90177-7e96-59db-b325-abc5f51c8721","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"bc7c22b0-dd64-50ad-8110-1fff4c8d6736","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"50f55046-7ca2-567f-94df-9c58f13770a5","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"2221cdd9-5576-5b5b-ad29-eff077930653","slug":"changes","fullItemName":"Changes"},{"id":"c755b06c-072d-5e60-be73-155dd664c37d","slug":"update","fullItemName":"Update"}]},{"id":"f5871d9a-dff3-59ce-a611-88d2ec41f5ce","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"513a86a0-e305-5e59-bd0d-1fb74a6e8689","slug":"goals","fullItemName":"Goals"},{"id":"87ea4699-bd41-5aeb-aa62-eac1fb591c4d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"c8b054a0-ee87-5f9e-aa8f-c1fdf8442a29","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"a8eb4582-f05d-5af5-ae78-497260724f93","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"6f29b0b8-4b10-5e26-9ece-4cec050b1eb0","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"79cb1d1a-ebd1-58c6-9bc5-2bfd006c22c1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"8d3187f5-2a99-5108-a7c9-dd601d729381","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"055aad08-f5af-5b2f-bda0-a35213a2a071","slug":"travel-vaccinations","fullItemName":"Travel vaccinations"},{"id":"c8d1352b-616b-5dff-9517-ea235b83e9d9","slug":"diseases-commonly-requiring-vaccination","fullItemName":"Diseases commonly requiring vaccination"},{"id":"041fa115-033d-5525-91ce-c43dbf593bd4","slug":"other-diseases-requiring-vaccination","fullItemName":"Other diseases requiring vaccination"},{"id":"1fe14ee1-a79f-565a-9380-ae3be597d7d5","slug":"where-these-diseases-are-prevalent","fullItemName":"Where these diseases are prevalent"},{"id":"68e09f74-2282-532f-ae34-064998823fc1","slug":"payment-for-travel-vaccinations","fullItemName":"Payment for travel vaccinations"}]},{"id":"0e45089d-2317-5ec5-8c73-f0709c003c48","fullItemName":"Management","slug":"management","subChapters":[{"id":"9c16c0cb-4e78-523d-914f-e884aea62565","slug":"initial-assessment-advice","fullItemName":"Scenario: Initial assessment and advice"},{"id":"f911dc04-ffd0-5a41-a3cb-b724797a7589","slug":"cholera","fullItemName":"Scenario: Cholera"},{"id":"422ff6d3-5810-5d3c-93b3-c5a67faaa0e1","slug":"hepatitis-a","fullItemName":"Scenario: Hepatitis A"},{"id":"01d49a70-70f4-547a-a551-ab524f99c944","slug":"hepatitis-b","fullItemName":"Scenario: Hepatitis B"},{"id":"5c77503c-2f59-5696-908b-125fe0e8e41c","slug":"japanese-encephalitis","fullItemName":"Scenario: Japanese encephalitis"},{"id":"8cb4ca86-fe31-5603-a75e-84413c2b5346","slug":"meningococcal-meningitis","fullItemName":"Scenario: Meningococcal meningitis"},{"id":"0e84be27-375b-55f5-9f51-d0e4cc422b58","slug":"poliomyelitis","fullItemName":"Scenario: Poliomyelitis"},{"id":"37a96f8b-4158-5e62-8e3d-6cedae506976","slug":"rabies","fullItemName":"Scenario: Rabies"},{"id":"8c237a0e-a760-55b2-b7b0-5383b7653be3","slug":"tetanus","fullItemName":"Scenario: Tetanus"},{"id":"85c90e1f-26f4-503b-b0b0-7c5a38930086","slug":"tick-borne-encephalitis","fullItemName":"Scenario: Tick-borne encephalitis"},{"id":"4e817d26-15f3-5ff7-a672-11caa36ffb68","slug":"typhoid-fever","fullItemName":"Scenario: Typhoid fever"},{"id":"5ec20606-2af2-556b-98a6-d8673a21a09d","slug":"yellow-fever","fullItemName":"Scenario: Yellow fever"},{"id":"e0a021ac-7c76-551a-97af-25341142d54f","slug":"hajj-umrah-pilgrims","fullItemName":"Scenario: Hajj and Umrah pilgrims"},{"id":"087d9fbb-1ec6-5f08-8e76-5df3a4a0b863","slug":"rapid-vaccination-courses-vaccination-at-short-notice","fullItemName":"Scenario: Rapid vaccination courses and vaccination at short notice"}]},{"id":"79dee816-dbdb-5426-8db3-2f095eedbff3","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"f1e9d43f-6815-516a-8511-3fd34a06525d","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a69fb594-d4b4-56e6-b46a-6283ead93e30","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"52eea726-d50b-5e4f-a22c-764c1961119d","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"b2033c1b-25a2-5a58-b99e-00baf9b02a96","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"6df4842b-8812-534e-975d-52d29f3a8ee4","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"81e42472-4b49-5390-8179-0d131f547700","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"86482706-09b2-5113-bd4e-261c392f6483","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"0e45089d-2317-5ec5-8c73-f0709c003c48","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"0e7fadd6-bcd4-5e66-b1b6-485171f89aad","slug":"indications-for-vaccine","fullItemName":"Indications for vaccine","depth":3,"htmlHeader":"<!-- begin field eda203b0-d17b-4bae-8369-29fc41ea3fd2 --><h3>Indications for vaccine</h3><!-- end field eda203b0-d17b-4bae-8369-29fc41ea3fd2 -->","summary":null,"htmlStringContent":"<!-- begin item 8d1ad31a-ed87-426e-99bc-bc15c05dd7e6 --><!-- begin field 07b88d83-7770-4664-90e0-afaf9d6d1abe --><ul><li><strong>Tetanus can potentially be contracted worldwide.</strong></li><li><strong>All people in the UK should receive tetanus vaccine as part of the childhood vaccination programme.</strong> For more information see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/immunizations-childhood/\">Immunizations - childhood</a>.</li><li><strong>For travellers, give a booster dose of tetanus/diphtheria/inactivated polio vaccine (Td/IPV) before departure, </strong>to people<strong> </strong>travelling to areas where medical attention may not be accessible and whose last dose of a tetanus-containing vaccine was more than 10 years previously (regardless of whether the person has received a full five-dose course of vaccine).</li></ul><!-- end field 07b88d83-7770-4664-90e0-afaf9d6d1abe --><!-- end item 8d1ad31a-ed87-426e-99bc-bc15c05dd7e6 -->","subChapters":[{"id":"1c919596-2d86-5bb7-bd53-5333e2b9a410","slug":"basis-for-recommendation-cf5","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field cf8931d2-14a7-4900-900d-c7d871af09ae --><h4>Basis for recommendation</h4><!-- end field cf8931d2-14a7-4900-900d-c7d871af09ae -->","summary":null,"htmlStringContent":"<!-- begin item cf5f690d-d349-4cbd-8556-05d919ebeb35 --><!-- begin field 10998e23-de00-43b3-add0-1c976f5056d1 --><ul><li>The recommendations on indications for tetanus vaccination are largely based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 30: Tetanus</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2020c</a>].</li></ul><!-- end field 10998e23-de00-43b3-add0-1c976f5056d1 --><!-- end item cf5f690d-d349-4cbd-8556-05d919ebeb35 -->","subChapters":[]}]},{"id":"c521fa8f-f918-56e0-a464-a6514ca496da","slug":"available-vaccines-vaccination-schedules","fullItemName":"Available vaccines and vaccination schedules","depth":3,"htmlHeader":"<!-- begin field b71579bb-9820-4ebf-a752-39aa217492cf --><h3>Available vaccines and vaccination schedules</h3><!-- end field b71579bb-9820-4ebf-a752-39aa217492cf -->","summary":null,"htmlStringContent":"<!-- begin item 10551c34-b71c-49ab-a30b-a0e2482969f1 --><!-- begin field 3822f8c7-dd78-4997-90a5-89a0cca4088f --><ul><li><strong>Tetanus vaccine is available as an inactivated vaccine and is only available as component of a combined product, with the choice of vaccine depending largely on the person's age and prior vaccination history. Available products are:</strong><ul><li>Boostrix IPV<sup>®</sup> (dTaP/IPV).</li><li>Infanrix Hexa<sup>®</sup> (dTaP/IPV/HBV/Hib).</li><li>Infanrix IPV<sup>®</sup> (dTaP/IPV).</li><li>Repevax<sup>®</sup> (dTaP/IPV).</li><li>Revaxis<sup>®</sup> (Td/IPV).</li></ul></li><li>Check that ALL people are up to date with the recommended five-dose schedule for tetanus immunization, regardless of travel arrangements.</li><li><strong>For children under 10 years of age who have not been vaccinated, </strong>vaccinate according to the routine childhood immunization programme. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/immunizations-childhood/\">Immunizations - childhood</a>.</li><li><strong>For children over 10 years of age and adults who have not been vaccinated give:</strong><ul><li>A primary course of three doses of vaccine (Td/IPV) 1 month apart.</li><li>Two booster doses — the first 5–10 years after the last dose of the primary course, and the second 10 years after the first booster.</li></ul></li><li><strong>For travellers who have not received a primary tetanus immunization course (three doses)</strong> it is usually worth giving the maximum number of doses of vaccine that the travel departure date allows and completing the course upon return.</li><li><strong>Give a booster dose to anyone who has not received two booster doses at appropriate intervals.</strong></li><li><strong>Give a booster dose to anyone who has been fully vaccinated (received five doses), has not received a booster dose in the last 10 years, and is travelling to areas where medical attention may not be accessible.</strong></li></ul><!-- end field 3822f8c7-dd78-4997-90a5-89a0cca4088f --><!-- end item 10551c34-b71c-49ab-a30b-a0e2482969f1 -->","subChapters":[{"id":"10511dad-dd17-59d9-96a3-d1b7d5f1e4be","slug":"basis-for-recommendation-1e3","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field afa668e7-4730-4d44-aaf7-9226f4c55477 --><h4>Basis for recommendation</h4><!-- end field afa668e7-4730-4d44-aaf7-9226f4c55477 -->","summary":null,"htmlStringContent":"<!-- begin item 1e3356fe-6c35-4406-b4f6-47bcabf6a2c4 --><!-- begin field 8a40320a-3769-405b-8f96-41dd74e8daa7 --><p>The information on available types of tetanus vaccine and vaccination schedules is based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 30: Tetanus </em>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2020c</a>].</p><h5>Vaccination of travellers who have not received a full primary tetanus immunization course</h5><ul><li>The recommendation to give the maximum number of doses of vaccine that the travel departure date allows and complete the course upon return for travellers who have not received a full primary tetanus immunization course (three doses) is pragmatic, based on what CKS considers to be good clinical practice.</li></ul><!-- end field 8a40320a-3769-405b-8f96-41dd74e8daa7 --><!-- end item 1e3356fe-6c35-4406-b4f6-47bcabf6a2c4 -->","subChapters":[]}]},{"id":"444604cd-b7e5-5c76-9a7d-c40a6718ce4d","slug":"contraindications-to-vaccine","fullItemName":"Contraindications to vaccine","depth":3,"htmlHeader":"<!-- begin field 5b91e4a3-cd2a-459f-9608-70c3ae01751b --><h3>Contraindications to vaccine</h3><!-- end field 5b91e4a3-cd2a-459f-9608-70c3ae01751b -->","summary":null,"htmlStringContent":"<!-- begin item 687c5408-e0da-4750-ab32-e749a71feca8 --><!-- begin field e744ca1f-997b-4d04-9f41-bb1ee20b05b6 --><ul><li><strong>Tetanus vaccine should not be given to people who have had:</strong><ul><li>A confirmed anaphylactic reaction, or serious systemic reaction following a previous dose.</li><li>A confirmed anaphylactic reaction to neomycin, streptomycin, or polymyxin B (which may be present in trace amounts).</li></ul></li><li><strong>Postpone tetanus vaccination if the person has a current severe febrile illness.</strong><ul><li>Minor illness without fever or systemic upset is <em>not</em> a valid reason to postpone immunization.</li></ul></li><li><strong>Children should continue immunization with tetanus-containing vaccines </strong>even with a history of fever (irrespective of severity), hypotonic–hyporesponsive episodes (HHE), persistent crying or screaming for more than 3 hours, or a severe local reaction (irrespective of extent) within 72 hours of a previous tetanus vaccination. </li><li><strong>Tetanus-containing vaccines may be given to pregnant women when protection is required without delay.</strong> There is no evidence of risk from vaccinating pregnant women or those who are breastfeeding with inactivated virus, bacterial vaccines, or toxoids.</li></ul><!-- end field e744ca1f-997b-4d04-9f41-bb1ee20b05b6 --><!-- end item 687c5408-e0da-4750-ab32-e749a71feca8 -->","subChapters":[{"id":"411a59d7-7882-55df-97e9-ac7394f1930a","slug":"basis-for-recommendation-6e2","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 06da77c3-1465-4aa1-8449-85d22bbdd062 --><h4>Basis for recommendation</h4><!-- end field 06da77c3-1465-4aa1-8449-85d22bbdd062 -->","summary":null,"htmlStringContent":"<!-- begin item 6e28f242-4a94-4087-a53d-20e21a24ca9c --><!-- begin field efda3d48-a3e6-4f83-bdf0-d63172f42f47 --><p>The recommendations on contraindications to tetanus vaccination are based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 30: Tetanus</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2020c</a>] and <em>Chapter 6: Contraindications and special considerations</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2017a</a>].</p><h5>Continuing vaccination in children with previous reactions</h5><ul><li>The recommendation to continue vaccination in children with previous systemic and local reactions is based on data showing that further doses were not associated with recurrence or worsening of the preceding events [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2020c</a>].</li></ul><!-- end field efda3d48-a3e6-4f83-bdf0-d63172f42f47 --><!-- end item 6e28f242-4a94-4087-a53d-20e21a24ca9c -->","subChapters":[]}]},{"id":"a1df2877-3cbf-54a5-8b84-93c05575eceb","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field c80344bd-3ecd-4562-95c3-5a0829f2daf4 --><h3>Adverse effects</h3><!-- end field c80344bd-3ecd-4562-95c3-5a0829f2daf4 -->","summary":null,"htmlStringContent":"<!-- begin item 84a4851a-edc2-42a0-8f32-ed4421edde77 --><!-- begin field 28dde3c3-3a7b-4df9-9149-191886b5e6ab --><ul><li>Pain, swelling, or redness at the injection site are common and may occur more frequently following subsequent doses. A small painless nodule may form at the injection site; this usually disappears and is of no consequence.</li><li>Confirmed anaphylaxis occurs extremely rarely. Data from the UK, Canada, and the USA point to rates of 0.65–3 anaphylaxis events per million doses of vaccine given.</li><li>Rarely, convulsions, high-pitched screaming, pallor, cyanosis, and limpness occur after vaccination with tetanus-containing vaccines.</li></ul><!-- end field 28dde3c3-3a7b-4df9-9149-191886b5e6ab --><!-- end item 84a4851a-edc2-42a0-8f32-ed4421edde77 -->","subChapters":[{"id":"75c915bb-bd08-5797-ae30-eec5bb34ea6c","slug":"basis-for-recommendation-e52","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field cd4a68d3-10e6-4689-a1d1-fb96d3a9cc5b --><h4>Basis for recommendation</h4><!-- end field cd4a68d3-10e6-4689-a1d1-fb96d3a9cc5b -->","summary":null,"htmlStringContent":"<!-- begin item e5206f45-292f-4043-9c3b-df28042904f0 --><!-- begin field b21d81d9-a48a-4a23-9483-04919fc7f641 --><p>The information on adverse effects of tetanus vaccination is based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 30: Tetanus</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2020c</a>].</p><!-- end field b21d81d9-a48a-4a23-9483-04919fc7f641 --><!-- end item e5206f45-292f-4043-9c3b-df28042904f0 -->","subChapters":[]}]},{"id":"a123e9d6-4d5e-5dff-961a-e0cfdeaa2617","slug":"how-to-administer-tetanus-containing-vaccines","fullItemName":"How to administer tetanus-containing vaccines","depth":3,"htmlHeader":"<!-- begin field bea73be0-6421-43ac-9c9a-8b267ec48da7 --><h3>How to administer tetanus-containing vaccines</h3><!-- end field bea73be0-6421-43ac-9c9a-8b267ec48da7 -->","summary":null,"htmlStringContent":"<!-- begin item b03cd3bc-b28c-49c6-8d3d-f0dd6ad6e334 --><!-- begin field bcf23378-5ef5-4695-815b-7594ab5cbfb3 --><ul><li><strong>Obtain written or verbal consent at the time of vaccination for people aged over 16 years.</strong><strong> For younger people it is usual to get consent from a person with parental responsibility.</strong><ul><li>Adults over 18 years of age are presumed to be competent to consent to treatment provided they can comprehend and retain the information they are given, and they can consider the facts and make an informed decision.</li></ul></li><li><strong>Ensure that:</strong> <ul><li>There are no <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/management/tetanus/#contraindications-to-vaccine\">contraindications</a> to the vaccine.</li><li>The person, parent, or carer has been fully informed about the vaccine and the vaccination procedure.</li><li>Possible <a class=\"topic-reference internal-reference\" href=\"/topics/immunizations-travel/management/tetanus/#adverse-effects\">adverse responses</a> have been discussed and the person, parent, or carer is aware of how to manage them. </li><li>The vaccine is correct, has been stored appropriately, and has not expired. </li></ul><ul><li>The vaccination site has been washed with soap and water if it is visibly dirty. </li></ul></li><li><strong>Tetanus-containing vaccine is usually given by intramuscular (IM) injection,</strong> into the upper arm in children and adults, or the anterolateral thigh in infants under 1 year of age. However, if the person has a bleeding disorder, the vaccine should be given by deep subcutaneous (SC) injection to reduce the risk of bleeding. </li><li><strong>Tetanus-containing vaccine can be given at the same time as other vaccines.</strong> If an additional vaccine is required on the same day, use separate limbs if possible, or inject at sites at least 2.5 cm apart. </li><li><strong>Record the date of administration, vaccine and product name, batch number, expiry date, dose administered, and site of administration for each vaccine.</strong> </li><li><strong>Observe the person after vaccination to detect immediate adverse reactions.</strong> Ensure any bleeding has stopped and check for any symptoms of anaphylaxis before they leave.<ul><li>Anaphylaxis is extremely rare, and usually becomes apparent within minutes. By the time the site has been checked for bleeding and documentation has been completed, most reactions will have become apparent. For more information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/angio-oedema-anaphylaxis/\">Angio-oedema and anaphylaxis</a>.</li></ul></li></ul><!-- end field bcf23378-5ef5-4695-815b-7594ab5cbfb3 --><!-- end item b03cd3bc-b28c-49c6-8d3d-f0dd6ad6e334 -->","subChapters":[{"id":"38f0b6b3-ddc2-53c7-b265-ad3d40ea1825","slug":"basis-for-recommendation-cc9","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 2b70a3fe-09e9-4ff7-8b60-0b9ec1bc5002 --><h4>Basis for recommendation</h4><!-- end field 2b70a3fe-09e9-4ff7-8b60-0b9ec1bc5002 -->","summary":null,"htmlStringContent":"<!-- begin item cc9763f9-bf3d-4c17-897f-5167929dc5f9 --><!-- begin field 29ad67bc-46dc-4426-b525-e1009d390082 --><p>The recommendations on administering tetanus-containing vaccines are based on expert opinion in the Department of Health publication <em>Immunisation against infectious disease (The Green Book) Chapter 30: Tetanus</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2020c</a>], <em>Chapter 2: Consent</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013e</a>], <em>Chapter 4: Immunisation procedures</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013f</a>], and <em>Chapter 8: Vaccine safety and adverse effects</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013g</a>], and are also pragmatic, based on what CKS considers to be good clinical practice.</p><h5>Obtaining consent</h5><ul><li>Consent for immunizations does not legally have to be in writing, but must be given voluntarily by a fully informed person who is able to make and communicate their decision. For children not competent to give or withhold consent, a person with parental responsibility can provide this [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013e</a>].</li></ul><h5>Site of administration</h5><div><ul><li>In people over the age of 1 year, vaccines are routinely given into the deltoid muscle as it is convenient, providing easy access, and it reduces the risk of localized reactions, which are common when vaccines are given subcutaneously.</li><li>The gluteal muscle should be avoided. The needle may not penetrate through adipose tissue into the muscle, and this may cause a poor immunological response to the vaccine. In addition, there is a risk of damage to underlying structures such as the sciatic nerve [<a class=\"bibliography-reference internal-reference\" href=\"/topics/immunizations-travel/references/\">PHE, 2013f</a>].</li></ul></div><!-- end field 29ad67bc-46dc-4426-b525-e1009d390082 --><!-- end item cc9763f9-bf3d-4c17-897f-5167929dc5f9 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}